Search Results - "Furlan, Thaísa Kowalski"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Certolizumab Pegol in Crohn's Disease Management: A Multicentric Brazilian Observational Study by Furlan, Thaisa Kowalski, Imbrizi, Marcello, Magro, Daniela, de Castro, Paula C. Senger, Nones, Rodrigo Bremer, Miranda, Eron Fabio, Kotze, Paulo G.

    Published in Journal of Coloproctology (01-09-2024)
    “…Introduction and Objectives Certolizumab Pegol (CZP) is an anti-TNF agent approved in Brazil for Crohn's disease (CD). There is a lack of data in Brazil and…”
    Get full text
    Journal Article
  2. 2

    USTEKINUMAB IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN OBSERVATIONAL STUDY by Castro, Paula Cenira Senger de, Magro, Daniéla Oliveira, Nones, Rodrigo Bremer, Furlan, Thaisa Kowalski, Miranda, Eron Fábio, Kotze, Paulo Gustavo

    Published in Arquivos de gastroenterologia (01-12-2022)
    “…Real-world data on the use of Ustekinumab (UST) in Brazilian and Latin American patients with Crohn's disease (CD) are scarce. The primary endpoint was…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    USTEKINUMAB IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN OBSERVATIONAL STUDY by Castro, Paula Cenira Senger de, Magro, Daniéla Oliveira, Nones, Rodrigo Bremer, Furlan, Thaisa Kowalski, Miranda, Eron Fábio, Kotze, Paulo Gustavo

    Published in Arquivos de gastroenterologia (01-10-2022)
    “…Real-world data on the use of Ustekinumab (UST) in Brazilian and Latin American patients with Crohn's disease (CD) are scarce. The primary endpoint was…”
    Get full text
    Journal Article
  6. 6